MaxCyte Inc (GB:MXCT)
LSE:MXCT
Holding GB:MXCT?
Track your performance easily

MaxCyte (MXCT) Technical Analysis

9 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
4Neutral
9Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
MaxCyte Inc’s (MXCT) Moving Averages Convergence Divergence (MACD) indicator is -5.48, suggesting MaxCyte Inc is a Sell.
MaxCyte Inc’s (MXCT) 20-Day exponential moving average is 312.81, while MaxCyte Inc’s (MXCT) share price is 317p, making it a Buy.
MaxCyte Inc’s (MXCT) 50-Day exponential moving average is 323.37, while MaxCyte Inc’s (MXCT) share price is 317p, making it a Sell.

MaxCyte (MXCT) Pivot Points

Sep 21, 2024, 07:49 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
311.33
311.67
311.33
311.67
311.33
311.67
311.33
Fibonacci
311.67
311.67
311.67
311.67
311.67
311.67
311.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MaxCyte (MXCT) Moving Averages

Sep 21, 2024, 07:49 AM
Period
Simple
Exponential
MA5
310.40Buy
311.09Buy
MA10
303.70Buy
309.51Buy
MA20
313.80Buy
312.81Buy
MA50
331.02Sell
323.37Sell
MA100
338.88Sell
330.53Sell
MA200
350.25Sell
333.20Sell
MaxCyte Inc’s (MXCT) 10-Day exponential moving average is 309.51, while MaxCyte Inc’s (MXCT) share price is 317p, making it a Buy.
MaxCyte Inc’s (MXCT) 100-Day exponential moving average is 330.53, while MaxCyte Inc’s (MXCT) share price is 317p, making it a Sell.
MaxCyte Inc’s (MXCT) stock price is 317p and MaxCyte Inc’s (MXCT) 50-day simple moving average is 331.02, creating a Sell signal.
MaxCyte Inc’s (MXCT) stock price is 317p and MaxCyte Inc’s (MXCT) 100-day simple moving average is 338.88, creating a Sell signal.
MaxCyte Inc’s (MXCT) stock price is 317p and MaxCyte Inc’s (MXCT) 200-day simple moving average is 350.25, creating a Sell signal.

MaxCyte (MXCT) Technical Indicators

Sep 21, 2024, 07:49 AM
Name
Value
Implied Action
RSI (14)
51.13
Neutral
STOCH (9,6)
89.24
Sell
STOCHRSI (14)
47.33
Neutral
MACD (12,26)
-5.48
Sell
ADX (14)
12.81
Buy
Williams %R
-46.00
Buy
CCI (14)
22.12
Neutral
ATR (14)
11.91
-
Ultimate Oscillator
62.27
Neutral
ROC
-2.46
Sell
MaxCyte Inc’s (MXCT) Relative Strength Index (RSI) is 51.13, creating a Neutral signal.
MaxCyte Inc’s (MXCT) Trend Strength Indicator (ADX) is 12.81, creating a Buy signal.
MaxCyte Inc’s (MXCT) Commodity Channel Index (CCI) is 22.12, creating a Neutral signal.
MaxCyte Inc’s (MXCT) Price Rate of Change (ROC) is -2.46, creating a Sell signal.

FAQ

Is MXCT a Buy, Hold, or Sell?
Based on MXCT’s technical indicators, MXCT is a Hold.
    What is MXCT’s RSI (14)?
    MXCT’s RSI (14) is 51.13, which suggests MXCT is a Neutral.
      What is MXCT’s MACD?
      MXCT’s MACD is -5.48, which suggests MXCT is a Sell.
        What is MXCT’s 5-day moving average?
        MXCT’s 5-day moving average is 310.40, which suggests MXCT is a Buy.
          What is MXCT’s 20-day moving average?
          MXCT 20-day moving average is 313.80, which suggests MXCT is a Buy.
            What is MXCT’s 50-day moving average?
            MXCT’s 50-day moving average is 331.02, which suggests MXCT is a Sell.
              What is MXCT’s 200-day moving average?
              MXCT’s 200-day moving average is 350.25, which suggests MXCT is a Sell.
                What is MXCT’s Williams % R (14)?
                MXCT’s Williams % R (14) is -46.00, which suggests MXCT is a Buy.
                  What is MXCT’s CCI (14)?
                  MXCT’s CCI (14) is 22.12, which suggests MXCT is a Neutral.
                    What is the share price of MaxCyte Inc?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis